Research's Scarlet List

, March 21, 2005), his name was added to a list of more than 40 other researchers currently enduring lesser penalties for similar but generally lesser crimes.

Written byAlison McCook
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

When well-known obesity researcher Eric Poehlman admitted he had fabricated data in 17 applications for US federal grants and agreed to be the first researcher barred for life from seeking federal funding (see The Scientist Daily News, March 21, 2005), his name was added to a list of more than 40 other researchers currently enduring lesser penalties for similar but generally lesser crimes.

The list, available at http://silk.nih.gov/public/cbz1bje.@www.orilist.html, is known as the Public Health Service (PHS) Administrative Actions Listing, and it names all researchers found guilty of some type of misconduct by the Office of Research Integrity (ORI), which typically penalizes them by temporarily barring them from receiving federal funds. Only days before Poehlman's case splashed across national headlines, another name, Gary Kammer, was added to the list. The Wake Forest University, NC, researcher admitted to falsifying and fabricating research findings from two grant submissions. According to the government, Kammer's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies